Home Bromides 103914-52-9
103914-52-9,MFCD00160560
Catalog No.:AA007WVW

103914-52-9 | 2-(4-Bromo-phenyl)-quinoline-4-carboxylic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$103.00   $73.00
- +
1g
95+%
in stock  
$177.00   $124.00
- +
10g
95+%
in stock  
$701.00   $491.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA007WVW
Chemical Name:
2-(4-Bromo-phenyl)-quinoline-4-carboxylic acid
CAS Number:
103914-52-9
Molecular Formula:
C16H10BrNO2
Molecular Weight:
328.1601
MDL Number:
MFCD00160560
SMILES:
Brc1ccc(cc1)c1nc2ccccc2c(c1)C(=O)O
NSC Number:
25669
Properties
Computed Properties
 
Complexity:
354  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
4.1  

Downstream Synthesis Route

[1]ChemischeBerichte,1955,vol.88,p.1123,1128

[1]Brownetal.[JournaloftheAmericanChemicalSociety,1946,vol.68,p.2705,2707]

[1]Nicolaie,E;Guengoer,T;Goyard,J;Cure,G;Fouquet,A;etal.[EuropeanJournalofMedicinalChemistry,1992,vol.27,#9,p.977-984]

[2]Aksenov,N.A.;Aksenova,I.V.;Dotsenko,V.V.;Kolokolov,F.A.;Kotlova,I.A.[RussianJournalofGeneralChemistry,2019,vol.89,#12,p.2413-2419][Zh.Obshch.Khim.,2019,vol.89,#12,p.1901-1908,8]

[3]CurrentPatentAssignee:SHANDONGUNIVERSITYOFTECHNOLOGY-CN103804419,2016,BLocationinpatent:Paragraph0032-0033

[4]Madak,JosephT.;Cuthbertson,ChristineR.;Miyata,Yoshinari;Tamura,Shuzo;Petrunak,ElyseM.;Stuckey,JeanneA.;Han,Yanyan;He,Miao;Sun,Duxin;Showalter,HollisD.;Neamati,Nouri[JournalofMedicinalChemistry,2018,vol.61,#12,p.5162-5186]

[5]More,PriyankaA.;Shankarling,GanapatiS.[NewJournalofChemistry,2017,vol.41,#21,p.12380-12383]

[6]Abdelwahid,MazinA.S.;Elsaman,Tilal;Mohamed,MalikS.;Latif,SaraA.;Mukhtar,MoawiaM.;Mohamed,MagdiA.[JournalofChemistry,2019,vol.2019]

[7]Buu-Hoietal.[JournalofOrganicChemistry,1953,vol.18,p.1209,1219]Lindwalletal.[JournaloftheAmericanChemicalSociety,1931,vol.53,p.317]Feist;Kuklinski[ArchivderPharmazie,1936,vol.274,p.244,250]

[8]Buu-Hoietal.[JournalofOrganicChemistry,1953,vol.18,p.1209,1219]Lindwalletal.[JournaloftheAmericanChemicalSociety,1931,vol.53,p.317]Feist;Kuklinski[ArchivderPharmazie,1936,vol.274,p.244,250]

[9]Yu,XiangY.;Hill,JasonM.;Yu,Guixue;Yang,Yifeng;Kluge,ArthurF.;Keith,Dennis;Finn,John;Gallant,Paul;Silverman,Jared;Lim,Audrey[BioorganicandMedicinalChemistryLetters,2001,vol.11,#4,p.541-544]

[10]Li,Jian;Chen,Jing;Gui,Chunshan;Zhang,Li;Qin,Yu;Xu,Qiang;Zhang,Jian;Liu,Hong;Shen,Xu;Jiang,Hualiang[BioorganicandMedicinalChemistry,2006,vol.14,#7,p.2209-2224]

[11]CurrentPatentAssignee:MITSUICHEMICALS,INC.-US5627193,1997,A

[12]CurrentPatentAssignee:ROCHEHOLDINGAG-US4560692,1985,A

[13]CurrentPatentAssignee:MYCOVIAPHARMACEUTICALSINC-WO2014/117090,2014,A1Locationinpatent:Page/Pagecolumn109-110

[14]CurrentPatentAssignee:INSTOFMATERIAMEDICASHANDONGACADOFMEDICALSC-CN106866713,2017,ALocationinpatent:Paragraph0024;0025;0026;0027

[15]Wang,Hao;Fang,Guiqian;Wang,Hongxiao;Dou,Jindi;Bian,Zhancun;Li,Ying;Chai,Huining;Wu,Zhongyu;Yao,Qingqiang[NewJournalofChemistry,2019,vol.43,#11,p.4385-4390]

[16]Hamdy,Rania;Elseginy,SamiaA.;Ziedan,NohaI.;Jones,ArwynT.;Westwell,AndrewD.[Molecules,2019,vol.24,#7]

[17]Bian,Zhancun;Fang,Guiqian;Wang,Ran;Wu,Zhongyu;Yao,Qingqiang;Zhan,Dongxue;Zhang,Guimin[BioorganicandMedicinalChemistryLetters,2020,vol.30,#17]

[18]Shaikh,SarfarazF.;Dhavan,PratikP.;Singh,PinkyR.;Vaidya;Jadhav;Ramana[RussianJournalofBioorganicChemistry,2021,vol.47,#2,p.572-583][Bioorg.Khim.]

[19]KumarSahoo,Santosh;NaiyazAhmad,Mohammad;Kaul,Grace;Nanduri,Srinivas;Dasgupta,Arunava;Chopra,Sidharth;MadhaviYaddanapudi,Venkata[Chemistryandbiodiversity,2022,vol.19,#7]

[20]Omidkhah,Negar;Hadizadeh,Farzin;Abnous,Khalil;Ghodsi,Razieh[JournalofMolecularStructure,2022,vol.1267]

[1]Nicolaie,E;Guengoer,T;Goyard,J;Cure,G;Fouquet,A;etal.[EuropeanJournalofMedicinalChemistry,1992,vol.27,#9,p.977-984]

[1]Li,Jian;Chen,Jing;Gui,Chunshan;Zhang,Li;Qin,Yu;Xu,Qiang;Zhang,Jian;Liu,Hong;Shen,Xu;Jiang,Hualiang[BioorganicandMedicinalChemistry,2006,vol.14,#7,p.2209-2224]

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-US4560692,1985,A

[3]CurrentPatentAssignee:INSTOFMATERIAMEDICASHANDONGACADOFMEDICALSC-CN106866713,2017,ALocationinpatent:Paragraph0025;0026;0027

Literature

Title: A series of quinoline analogues as potent inhibitors of C. albicans prolyl tRNA synthetase.

Journal: Bioorganic & medicinal chemistry letters 20010226

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:103914-52-9 Molecular Formula|103914-52-9 MDL|103914-52-9 SMILES|103914-52-9 2-(4-Bromo-phenyl)-quinoline-4-carboxylic acid